RxSight (RXST) Amortization of Deferred Charges (2020 - 2023)

RxSight (RXST) has reported Amortization of Deferred Charges for 4 consecutive years, with $4000.0 the latest figure, recorded in Q3 2023.

• For the quarter ending Q3 2023, Amortization of Deferred Charges fell 97.2% year-over-year to $4000.0; the trailing twelve-month figure through Jun 2024 stood at $4000.0 (down 99.3% YoY), and the FY2023 full-year result was $287000.0, down 48.01% from the prior year.
• Amortization of Deferred Charges eased to $4000.0 in Q3 2023 per RXST's latest filing, from $142000.0 in the prior quarter.
• Across five years, Amortization of Deferred Charges topped out at $144000.0 in Q4 2022 and bottomed at $4000.0 in Q3 2023.
• Historically, Amortization of Deferred Charges has averaged $118083.3 across 4 years, with a median of $132000.0 in 2021.
• The sharpest annual moves came in 2021 and 2023: Amortization of Deferred Charges jumped 55.29% in 2021, then slumped 97.2% in 2023.
• Over 4 years, Amortization of Deferred Charges stood at $85000.0 in 2020, then surged by 55.29% to $132000.0 in 2021, then gained by 9.09% to $144000.0 in 2022, then tumbled by 97.22% to $4000.0 in 2023.
• According to Business Quant data, Amortization of Deferred Charges over the past three periods registered $4000.0, $142000.0, and $141000.0 for Q3 2023, Q2 2023, and Q1 2023 respectively.